Title: Haipeng Li - Innovator in Polymerization Inhibition
Introduction
Haipeng Li is an inventor based in Jiaozuo, China. He is associated with Boai Nky Medical Holdings Ltd. Although he currently holds no granted patents, his work in the field of polymerization inhibition is noteworthy. His innovative approach focuses on enhancing the stability and usability of N-vinyl pyrrolidone monomers.
Latest Patent Applications
Haipeng Li's latest patent application is titled "Polymerization Inhibitor for N-Vinyl Pyrrolidone Monomer and Use Thereof." This application discloses a polymerization inhibitor that is selected from an inorganic weak acid potassium salt and/or an organic acid potassium salt. The polymerization inhibitor is added to N-vinyl pyrrolidone monomers and is sealed and preserved under the protection of inert gas. The addition amount of the polymerization inhibitor is specified to be between 0.005-0.2% by mass concerning the mass of the N-vinyl pyrrolidone monomers. This innovative method effectively inhibits the self-polymerization of the N-vinyl pyrrolidone monomers, thereby extending their shelf life. Additionally, it significantly reduces the chromaticity and toxicity of the monomers. The polymerization inhibitor can be used directly during solution polymerization without being removed, ensuring that the chromaticity of the polymerization solution remains unaffected.
Conclusion
Haipeng Li's contributions to the field of polymerization inhibition demonstrate his commitment to innovation and improvement in chemical applications. His work has the potential to enhance the stability and safety of various monomers used in industry.